Clinical management and resolution of stomatitis in BOLERO-2.
Alejandra Perez(University of Miami), Howard A. Burris(Deaconess Hospital), Matthias Geberth(Praxis für Hämatologie und Onkologie), Gabriel N. Hortobágyi(The University of Texas MD Anderson Cancer Center), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Tarek Sahmoud(European Organisation for Research and Treatment of Cancer), Francis P. Arena, Kathleen I. Pritchard, Tibor Csőszi, Janice F. Eakle(Florida Cancer Specialists & Research Institute), Vichien Srimuninnimit(Siriraj Hospital), Tanya Taran, Puttisak Puttawibul(Prince of Songkla University), Hope S. Rugo(City of Hope), Ashok Panneerselvam(Novartis (United States)), Lowell L. Hart(Florida Cancer Specialists & Research Institute), Shinzaburo Noguchi(Hyogo Prefectural Nishinomiya Hospital), José Baselga(Novartis (Switzerland)), Daniel Yick Chin Heng(University of Calgary), E. Chouinard(Cambridge Memorial Hospital)
Cited by 3
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k